Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
Li, Charles, Bonazzoli, Elena, Bellone, Stefania, Choi, Jungmin, Dong, Weilai, Menderes, Gulden, Altwerger, Gary, Han, Chanhee, Manzano, Aranzazu, Bianchi, Anna, Pettinella, Francesca, Manara, Paola,Мова:
english
Журнал:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1814027116
Date:
December, 2018
Файл:
PDF, 986 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
